Risk of artery dissection during systemic exposure to vascular endothelial growth factor pathway inhibitors
Jun Okui, Takashi Waki, Kazuhiro Kajiyama, Sono Sawada, Shinya Watanabe, Yukari Namba, Ayano Kobayashi, Shuichi Kawarasaki, Kohei Amakasu, Toyotaka Iguchi, Naoya Horiuchi, Yoshiaki Uyama · 2024
Read Risk of artery dissection during systemic exposure to vascular endothelial growth factor pathway inhibitors by Jun Okui, Takashi Waki, Kazuhiro Kajiyama, Sono Sawada, Shinya Watanabe, Yukari Namba, Ayano Kobayashi, Shuichi Kawarasaki, Kohei Amakasu, Toyotaka Iguchi, Naoya Horiuchi, Yoshiaki Uyama (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11609114.txt.
Description
Jun Okui and a large team of co-authors assess a rare risk of cancer drugs in a 2024 study from Japan. The drugs block a growth signal for blood vessels, and whether they raise the risk of a torn artery wall was unknown. The team use a national claims database that covers nearly the whole population to compare twelve such drugs.
They use one drug, whose label already lists this risk in Japan, as the yardstick. Rates for the other drugs were like or above that yardstick, and all were far above the rate in the general population of the same age and sex mix. The authors call this a class wide risk that needs care in practice.
Catalog record
| CREATOR | Jun Okui, Takashi Waki, Kazuhiro Kajiyama, Sono Sawada, Shinya Watanabe, Yukari Namba, Ayano Kobayashi, Shuichi Kawarasaki, Kohei Amakasu, Toyotaka Iguchi, Naoya Horiuchi, Yoshiaki Uyama |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |